Clinical Endpoint Bioequivalence Study of Fluticasone Propionate & Salmeterol Xinafoate (100mg/50mg)

Condition:   Asthma Interventions:   Drug: Fluticasone propionate/salmeterol;   Drug: Advair Diskus, 100 Mcg-50 Mcg Inhalation Powder;   Drug: Placebo Sponsor:   West-Ward Pharmaceutical Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials